These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6255136)

  • 1. Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function.
    Wood PL; Stotland M; Richard JW; Rackham A
    J Pharmacol Exp Ther; 1980 Dec; 215(3):697-703. PubMed ID: 6255136
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
    Lubetzki C; Chesselet MF; Glowinski J
    J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of narcotics on brain dopamine metabolism and their relevance for "psychomotor" effects.
    Kuschinsky K
    Arzneimittelforschung; 1976 Apr; 26(4):563-7. PubMed ID: 8059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat.
    Chesselet MF; Cheramy A; Reisine TD; Lubetzki C; Glowinski J; Fournie-Zaluski MC; Roques B
    Life Sci; 1982 Nov 15-22; 31(20-21):2291-4. PubMed ID: 6298522
    [No Abstract]   [Full Text] [Related]  

  • 5. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences.
    Wood PL
    Peptides; 1983; 4(5):595-601. PubMed ID: 6318197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors.
    Noble F; Cox BM
    Brain Res; 1996 Apr; 716(1-2):107-17. PubMed ID: 8738226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
    Asensio VJ; Miralles A; García-Sevilla JA
    Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered.
    Airavaara M; Mijatovic J; Vihavainen T; Piepponen TP; Saarma M; Ahtee L
    Synapse; 2006 May; 59(6):321-9. PubMed ID: 16437537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis.
    Makman MH; Bilfinger TV; Stefano GB
    J Immunol; 1995 Feb; 154(3):1323-30. PubMed ID: 7822801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2001 Nov; 299(2):760-7. PubMed ID: 11602692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
    Chen L; Togasaki DM; Langston JW; Di Monte DA; Quik M
    Neuroscience; 2005; 132(2):409-20. PubMed ID: 15802193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lack of affinity of prostaglandins to dopaminergic and opiate receptors in the rat striatum.
    Członkowski A; Herman Z
    Pol J Pharmacol Pharm; 1980; 32(5):639-41. PubMed ID: 6267565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
    Steiner H; Gerfen CR
    J Comp Neurol; 1995 Mar; 353(2):200-12. PubMed ID: 7745131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of endogenous cannabinoids in cerebral reward mechanisms].
    Wenger T; Fürst S
    Neuropsychopharmacol Hung; 2004 Mar; 6(1):26-9. PubMed ID: 15125311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists.
    Iwamoto ET
    J Pharmacol Exp Ther; 1981 May; 217(2):451-60. PubMed ID: 6262485
    [No Abstract]   [Full Text] [Related]  

  • 19. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
    Rady JJ; Elmer GI; Fujimoto JM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate receptor upregulation and functional supersensitivity.
    Zukin RS; Tempel A; Gardner EL
    NIDA Res Monogr; 1984; 54():146-61. PubMed ID: 6099871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.